维普中文期刊产品整合服务
301篇 您的检索式:作者名="Taal"
    题名 作者 年代 出处 被引量
1Hidden risks associated with conventional short intermittent hemodialysis:A call for action to mitigate cardiovascular risk and morbidity显示文摘The development of maintenance hemodialysis(HD)for end stage kidney disease patients is a success story that continues to save many lives.Nevertheless,intermittent renal replacement therapy is also a source of recurrent stress for patients.Conventional thrice weekly short HD is an imperfect treatment that only partially corrects uremic abnormalities,increases cardiovascular risk,and exacerbates disease burden.Altering cycles of fluid loading associated with cardiac stretching(interdialytic phase)and then fluid unloading(intradialytic phase)likely contribute to cardiac and vascular damage.This unphysiologic treatment profile combined with cyclic disturbances including osmotic and electrolytic shifts may contribute to morbidity in dialysis patients and augment the health burdenof treatment. As such, HD patients are exposed to multiple stressors including cardiocirculatory,inflammatory, biologic, hypoxemic, and nutritional. This cascade of events can be termed thedialysis stress storm and sickness syndrome. Mitigating cardiovascular risk and morbidityassociated with conventional intermittent HD appears to be a priority for improving patientexperience and reducing disease burden. In this in-depth review, we summarize the hidden effectsof intermittent HD therapy, and call for action to improve delivered HD and develop treatmentschedules that are better tolerated and associated with fewer adverse effects.Bernard Canaud Jeroen P Kooman Nicholas M Selby Maarten Taal Andreas Maierhofer Pascal Kopperschmidt Susan Francis Allan Collins Peter Kotanko 2022World Journal of Nephrology2022,11,2:2
2Renoprotective benefits of RAS inhibition : from ACEI to angiotens in II antagonists 显示文摘TAAL M W BRENNER B M 2000Kidney Int2000,57,5:1
3The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease 显示文摘Taal MW Thurston V McIntyre NJ 2014Kidney Int2014,,:1
4Metastatic carcinoid tumors:a clinical review显示文摘Zuetenhorst JM Taal BG 2005Oncologist2005,10,2:1
5Preventing catheter related infections in haemodialysis patients显示文摘TAAL M W FLUCK R J MCLNTYRE C W 2006Curr Opin Nephrol Hypertens2006,15,6:1
6Renoprotective benefits of RAS in,hibition:from ACEI to angiotensinlIantagonists显示文摘TAAL Mw BRENNER BM 2000Kidney Int2000,57,18:1
7T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication显示文摘Hongxiang Liu Hongtao Ye Agnes Ruskone-Fourmestraux Daphne De Jong Stefano Pileri Christian Thiede Anne Lavergne Henk Boot Giancarlo Caletti Thomas Wündisch Thierry Molina Babs G. Taal Sabattini Elena Togliani Thomas Pier Luigi Zinzani Andreas Neubauer Ma 2002Gastroenterology2002,,5:1
8Pathogenesis of diabetic nephropathy: focus on transforming growth factor-β and connective tissue growth factor显示文摘Olga V. Sakharova Maarten W. Taal Barry M. Brenner 2001Current Opinion in Nephrology and Hypertension2001,,6:1
9Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney显示文摘Taal M W Zandi-Nejad K Weening B 2000J Kidney Int2000,58,4:1
10Hyponatremia in intracranial disorders显示文摘Coenraad M J Meinders AE Taal JC 2001Neth J Med2001,58,3:1
11Histological grading with clinical relevance in gastric mucosa-associated lymphoid tissue (MALT) lymphoma显示文摘DE JONE D BOOT H TAAL B 2000Recent Resuits Cancer Res2000,156,1:1
12Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney显示文摘Taal MW Zandi-Nejad K Weening B 2000Kidney Int2000,58,4:1
13Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis 显示文摘Veehof MM ten Klooster PM Taal E 2008J Rheumato12008,35,4:1
14Hyponatremia in intracranial disorders 显示文摘Coenraad MJ Meinders AE Taal JC 2001Neth J Med2001,58,3:1
15Adherence oftunnelled haemodialysis catheter to superior vena ca-val stent: successful percutaneous removal显示文摘McIntyre CW Taal MW Fluck RJ 2003NephrolDial Transplant2003,18,2:1
16Clinical features,mechanisms,and management of pseudoprogression in malignant gliomas显示文摘Brandsma D Stalpers L Taal W 2008Lancet Oncol2008,9,5:1
17Renoprotective benefits of RAS inhihiition: from ACEI to angiotensin II antagonists显示文摘Taal MW Brenner BM 2000Kidney lnt2000,57,:1
18Pathogenesis of diabetic nephropathy:focus on transforming growth factor beta and connective tissue growth factor显示文摘 Taal M W Brenner BM 2001Curr Opin Nephrol Hypertens2001,10,6:1
19Vascular calcifi- cation and cardiovascular function in chronic kidney disease显示文摘Sigrist M Bungay P Taal MW 2006Nephrol Dial Transplant2006,21,3:1
20Hyponatremia intracranial disorders显示文摘Coenraad MJ Meinders AE Taal JC 2001Neth J Med2001,58,3:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费